SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.065+1.2%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Skywatcher who wrote (55)7/30/1997 12:32:00 PM
From: Haolin Ni   of 645
 
Hi, Chris,

Thank you telling us Brad is an extremely knowledgeable person who is in the financial industry.

Who can dream a new products of AVIR will take away all the market with a products 4 times more expensive than other vaccine using and creat another almost same size market it does not exists in the US the moment? Only such person, who says flu is killer and AIDS is not killer, can say so. No to mention the products is at least two years away and has not been approved by FDA, which no one can say so with 100% confidence.

Do you notice PLC's products? Last week it was upgraded by some experts but the product was non-approval by the panel. The price of PLC dropped more than 50% yestoday.

I brought 3000 shares of PLC yestoday, which is much more better long term investment than AVIR.

Good luck!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext